Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Sunshine Biopharma's price to book ratio was 0.0× on Oct 19, 2026, against 3.1× a year earlier. Over the last 5 years it ranged from 0.0× to 188.2×, with a median of 2.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.0× | −2.3 |
| 2025 | Dec 31, 2025 | 2.3× | −0.1 |
| 2024 | Dec 31, 2024 | 2.4× | −61.1 |
| 2023 | Dec 29, 2023 | 63.5× | +3.6 |
| 2022 | Dec 30, 2022 | 59.9× | – |